Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 11,277

Document Document Title
WO/2008/054892A2
A composition and method for the preparation of micro-particles of chitin (a naturally occurring polymer of N-acetyl-D-glucosamine), the characterization of chitin micro-particles as an immune adjuvant and the use of chitin micro-particl...  
WO/2008/052077A2
One embodiment of the present inventionis a process of making sucrose-6-ester from sucrose by transesterification in the presence of a solid super acid catalyst such as SO4 2---TiO2/Al2O3 or SO4 2---TiO2. The sucrose-6-acetate is then ch...  
WO/2008/049974A2  
WO/2008/046463A1
The invention relates to the subject matters characterized in the claims, namely metal chelates having a perfluorinated PEG group, a method for the production thereof, and the use thereof, a method for the production thereof, and the use...  
WO/2008/047658A1
An object is to provide a safe and convenient means for preventing or treating a disease in an avian or mammal, particularly a farm animal, specifically to provide a means for preventing or treating an inflammatory disease in a farm anim...  
WO/2008/047249A3
The invention relates to α -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of ...  
WO/2008/047174A1
The invention relates to α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of m...  
WO/2008/047249A9
The invention relates to α -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of ...  
WO/2008/047249A2
The invention relates to α -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of ...  
WO/2008/037923A1
The invention relates to new compounds of 5-thioxilose, preferably derivatives of the 5-thioxilopyranose type, and to a method for preparing the same and their use as the active ingredient of drugs mainly intended for treating or prevent...  
WO/2008/039492A3
Provided are polymorphic forms of valrubicin and processes for their preparation.  
WO/2008/039492A2
Provided are polymorphic forms of valrubicin and processes for their preparation.  
WO/2008/032817A1
It is intended to provide a novel sugar chain which has an activity against Helicobacter pylori and a method of producing the same. Namely, a compound represented by the following general formula (1) is provided: (1)wherein Ac represents...  
WO/2008/029294A2
The present invention relates to methods of synthesizing anthracycline derivatives. Among other advantages, these methods offer simple and efficient manipulation of substituents on the sugar ring of anthracyclines. For example, the C-3 '...  
WO/2008/028667A2
The present invention relates to adjuvants of the glycolipid type and their uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new uses of compounds useful as adjuvants for prophylactic a...  
WO/2008/030121A1
The invention relates to sweetening compositions obtained from the Luo Han Guo fruit, a member of the Cucurbiticeae family. The compositions are free of bitter-tasting impurities, have a light colour and contain about 16-75% mogroside V ...  
WO/2008/028966A1
The novel crystalline and polymorphic forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phen yl] hexane have advantageous properties and can be used in pharmaceutical and dermatological compositions.  
WO/2008/030112A1
The invention relates to methods of preparing compounds of formula (II) wherein Z represents -OR1 or -N(R2)R2a-, where R1 is lower alkylene (C1-C6), R2 is lower alkyl or H and R2a is lower alkylene (C1-C6) or H;Q is absent when R2a is H ...  
WO/2008/028667A3
The present invention relates to adjuvants of the glycolipid type and their uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new uses of compounds useful as adjuvants for prophylactic a...  
WO/2008/029294A3
The present invention relates to methods of synthesizing anthracycline derivatives. Among other advantages, these methods offer simple and efficient manipulation of substituents on the sugar ring of anthracyclines. For example, the C-3 '...  
WO/2008/028060A3
This invention provides a method for treating cancer by blocking the migration, metastasis of cancer cells, growth of cancers wherein the cancers comprise breast cancer, leukocyte cancer, liver cancer, ovarian cancer, bladder cancer, pro...  
WO/2008/028060A2
This invention provides a method for treating cancer by blocking the migration, metastasis of cancer cells, growth of cancers wherein the cancers comprise breast cancer, leukocyte cancer, liver cancer, ovarian cancer, bladder cancer, pro...  
WO/2008/028050A2
The present invention relates to methods of use of glycosyltransferases and related novel compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomolecules and numerous one-pot rea...  
WO/2008/028050A3
The present invention relates to methods of use of glycosyltransferases and related novel compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomolecules and numerous one-pot rea...  
WO/2008/020490A1
Disclosed is a substance having an ability of inhibiting a testosteron-5α-reductase activity, an ability of inhibiting or reducing the proliferation of a cancer cell, an ability of inhibiting a cyclooxygenase, an ability of inhibiting a...  
WO/2008/018448A1
At least one kind of a biosurfactant, in particular, a mannosyl alditol lipid (MEL, MML or the like) or a triacyl derivative of the same is used as an active ingredient. Thus, it becomes possible to provide an activator or an anti-aging ...  
WO/2008/016132A1
Disclosed is a benzyl phenyl glucopyranoside derivative having excellent inhibitory effect on human SGLT1 and/or SGLT2 activity. Specifically disclosed is a compound represented by the general formula (I) or a pharmacologically acceptabl...  
WO/2008/016007A1
A phthalic acid derivative represented by the general formula (1) has an inhibitory activity on metallo-β-lactamase. Therefore, when used in combination with a β-lactam antibiotic, the derivative can inhibit the deactivation of the β-...  
WO/2008/010324A1
The invention relates to a fusicoccin derivative and a cell differentiation-inducing agent containing the same as an active ingredient, an anti-hematologic malignancy agent, an antitumor agent, an agent for enhancing an antitumor effect,...  
WO/2008/011588A3
Bromoglufosfamide and related compounds are useful in the treatment of cancer and other hyperproliferative diseases. Glufosfamide and bromoglufosfamide are synthesized by reacting the corresponding tetracetyl derivatives with MeOH and a ...  
WO/2008/007003A2
Composition (C) comprising for 100% of its mass: from 0.5% to 30% of one or more alcohols having the formula (IV): R1-OH (IV) wherein R1 represents a saturated or unsaturated, linear or branched aliphatic group, having from 8 to 36 carbo...  
WO/2008/007003A3
Composition (C) comprising for 100% of its mass: from 0.5% to 30% of one or more alcohols having the formula (IV): R1-OH (IV) wherein R1 represents a saturated or unsaturated, linear or branched aliphatic group, having from 8 to 36 carbo...  
WO/2008/003314A1
The present invention provides a method of preparing a glycoside of a mono- or diacylglycerol product from a plant material. The method comprises the steps of: (i) optionally milling the plant material, (ii) extracting the optionally mil...  
WO/2007/148631A1
The object is to provide a composition which can significantly promote the production of an equol. When added to a pharmaceutical agent or a beverage/food, the composition can exerts an effect of preventing a vascular disease because of ...  
WO/2007/145362A1
It is intended to provide a novel glyceroglycolipid produced by Mycoplasma pneumoniae. This glyceroglycolipid can be used as a diagnostic marker for a disease caused by Mycoplasma pneumoniae.  
WO/2007/143052A1
Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with Pseudomonas bacteria. Such infections include Pseudo...  
WO/2007/142150A1
Disclosed are: a novel aminoglycoside antibiotic which has an excellent anti-bacterial activity against an infection-inducing bacterium, particularly MRSA, and also has low renal toxicity; and a process for production of the antibiotic. ...  
WO/2007/139556A1
A method of treating cancer in a subject comprising administering to the subject in need of the treatment a therapeutically effective amount of an alkylating agent such as temozolomide and a substituted anthracycline compound.  
WO/2007/131444A1
The present invention provides two kinds of new crystallographic form of the compound 3,4',5-trihydroxyl-stilbene-3-beta-D-glucoside, their manufature and medication combination comprising II-crystallographic form or III- crystallographi...  
WO/2007/128480A3
The present invention relates to thioglycosides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds, as well as pharmaceutical compositions containing at least one of these thioglycosi...  
WO/2007/128480A2
The present invention relates to thioglycosides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds, as well as pharmaceutical compositions containing at least one of these thioglycosi...  
WO/2007/126117A1
The object is to provide a novel phenyl 5-thioglucoside compound which can control IGT (impaired glucose tolerance) by inhibiting the SGLT1 activity and inhibiting the absorption of glucose through a digestive tract. Provided is a phenyl...  
WO/2007/125176A1
The invention relates to an improved process for the production of a sugar alcohol from the corresponding sugar through catalytic hydrogenation. Especially, the invention relates to a process for reducing the interference of sugar-derive...  
WO/2007/123403A1
The present invention discloses a therapeutic target for the treatment of cyst ic fibrosis. It was found that inhibition of non-lysosomal glucosylceramidase (GBA2) sufficiently restores chloride current in cells from CF patients carrying...  
WO/2007/124102A3
The present invention concerns the isolation of phlorizin from plants of the genus Lithocarpus, phlorizin-containing compositions and their uses.  
WO/2007/124102A2
The present invention concerns the isolation of phlorizin from plants of the genus Lithocarpus, phlorizin-containing compositions and their uses.  
WO/2007/118947A1
Compounds derived from α-C-phenyl-N-tert-butylnitrone, a process for the preparation thereof and use thereof for the preparation of medicaments for use in preventing or treating oxidative stress-related diseases.  
WO/2007/117500A3
Processes for the synthesis of lipochitooligosaccharides were developed. A fully acylated oligoglucosamine precursor is prepared and reacted with a glucosamine monomer that has an amine protecting phthaloyl group. With removal of the pht...  
WO/2007/118143A3
A method for producing isolated limonoid glucoside compounds is disclosed which includes extracting a quantity of defatted citrus seed powder with a solvent, filtering the resulting extract to yield a particle free extract and concentrat...  
WO/2007/117500A2
Processes for the synthesis of lipochitooligosaccharides were developed. A fully acylated oligoglucosamine precursor is prepared and reacted with a glucosamine monomer that has an amine protecting phthaloyl group. With removal of the pht...  

Matches 551 - 600 out of 11,277